← Back to Analyst Consensus 
BDSX Buy
BIODESIX INC
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 2, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Sep 25, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 10, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 25, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| Jun 18, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 15, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| May 5, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Feb 27, 2026 | William Blair | upgrade | Market Perform → Outperform | $0 | 48% |
| Feb 17, 2026 | Canaccord Genuity | maintain | Buy → Buy | $20 | 48% |
| Sep 19, 2025 | Canaccord Genuity | maintain | Buy → Buy | $20 | 48% |
| May 21, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $2 | 55% |
| May 14, 2025 | Craig-Hallum | maintain | Buy → Buy | $1.5 | 54% |
| May 14, 2025 | Lake Street | maintain | Buy → Buy | $2 | 47% |
| May 14, 2025 | Canaccord Genuity | maintain | Buy → Buy | $1.5 | 48% |
| May 14, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Apr 29, 2025 | Canaccord Genuity | maintain | Buy → Buy | $2.5 | 48% |
| Sep 16, 2024 | Scotiabank | initiate | — → Sector Outperform | $3 | 55% |
| Jul 26, 2024 | Craig-Hallum | initiate | — → Buy | $3 | 54% |
| May 13, 2024 | TD Cowen | initiate | — → Buy | $2.8 | 54% |
| May 3, 2024 | Lake Street | initiate | — → Buy | $3 | 47% |
| Mar 4, 2024 | Canaccord Genuity | reiterate | Buy → Buy | $3.5 | 48% |
| Dec 7, 2023 | Canaccord Genuity | reiterate | Buy → Buy | $3.5 | 48% |
| May 12, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $5 | 54% |
| Apr 20, 2022 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Nov 17, 2021 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $11 | 54% |
| May 12, 2021 | Morgan Stanley | maintain | — → Overweight | $23 | 54% |
| Mar 18, 2021 | Morgan Stanley | maintain | — → Overweight | $25 | 54% |
| Feb 2, 2021 | Canaccord Genuity | maintain | — → Buy | $31 | 48% |
| Nov 23, 2020 | William Blair | initiate | — → Outperform | $0 | 48% |
| Nov 23, 2020 | BTIG | initiate | — → Buy | $22 | 52% |
| Nov 23, 2020 | Morgan Stanley | initiate | — → Overweight | $20 | 54% |
Price Target Trend
Apr 2, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days